
Gene Screening Reduces Early Disease Deaths by 25%
A study by Stanford University and Genomics suggests that genetic screening could reduce premature deaths from diseases like cancer and diabetes by 25% by identifying high-risk individuals early. Using polygenic risk scores, researchers found that those at high genetic risk reach average disease risk levels much earlier, allowing for earlier intervention and treatment. This approach could significantly improve public health outcomes and reduce healthcare costs by tailoring screening programs to genetic risk profiles.



